Chemed EV/EBIT CHE
Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2011.
- Today, Nov 2, 2026
- 20.6×
- 10-year median
- 21.6×
- Against its 10-year history
- 39th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 12.8× to 32.0×
- Peer median
- 17.7×
Chemed's EV/EBIT is 20.6× as of Nov 2, 2026.
That is below its ten-year median of 21.6×, close to the middle of its last ten years.
Over that time it ranged from 12.8× in Nov 2016 to 32.0× in Feb 2020.
The median for 10 hospital and care facility stocks of a similar size is 17.7×.
EV/EBIT over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 20.6× | 15.2× | 21.0× |
| 2025 | 17.5× | 16.2× | 24.1× |
| 2024 | 21.3× | 21.3× | 29.0× |
| 2023 | 28.2× | 20.8× | 28.6× |
| 2022 | 21.3× | 17.6× | 22.9× |
| 2021 | 21.3× | 17.8× | 27.1× |
| 2020 | 26.3× | 22.1× | 32.0× |
| 2019 | 28.6× | 19.2× | 28.8× |
| 2018 | 19.5× | 18.7× | 25.0× |
| 2017 | 19.8× | 15.6× | 20.1× |
| 2016 | 15.2× | 11.8× | 15.2× |
| 2015 | 14.1× | 11.8× | 15.3× |
| 2014 | 12.4× | 9.0× | 14.6× |
| 2013 | 9.1× | 7.7× | 10.4× |
| 2012 | 8.9× | 7.5× | 9.5× |
| 2011 | 7.9× | 7.8× | 11.6× |
Against its peers
Companies in Medical - Care Facilities nearest Chemed's size, closest first, today.
| Company | EV/EBIT |
|---|---|
| CHEChemed | 20.6× |
| PACSPACS | 17.8× |
| CONConcentra Group Holdings Parent | 17.5× |
| LFSTLifeStance Health | 65.2× |
| SHCSotera Health | 25.7× |
| ENSGEnsign | 21.9× |
| OPCHOption Care Health | 17.1× |
| UHSUniversal Health Services | 7.5× |
| DVADavita | 10.4× |
| BTSGBrightSpring Health Services | 31.6× |
| EHCEncompass Health | 14.9× |
| Peer median | 17.7× |
Where Chemed ranks
What the EV/EBIT tells you
What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.
Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.
More on Chemed
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.